Avalo Therapeutics Inc

:CERC   4:00:00 PM EDT
1.74
-0.07 (-3.87%)
Products

Cerecor Announces FDA Acceptance Of Investigational New Drug Application For CERC-007 For Treatment Of Relapsed Or Refractory Multiple Myeloma

Published: 12/08/2020 12:27 GMT
(CERC) - Cerecor Announces FDA Acceptance of Investigational New Drug Application for Cerc-007 for Treatment of Relapsed Or Refractory Multiple Myeloma.
Cerecor Inc - Initial Data is Expected in Q1 of 2021.